Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Vial will be at the SITC 37th Annual Meeting

November 8-12, 2022 | Boston, MA

Vial is proud to be an exhibitor at the Society for Immunotherapy of Cancer 37th Annual Meeting. Come visit us at Booth #645.

Meet with us
DPHARM

Let us know if you’d like to connect with us before or at the event by submitting the form below.

Vial staff attending the event:

Simon Burns
Simon Burns
Co-founder & CEO
Rich McCormick, Jr.
VP of Oncology
Wendy Pinson
Wendy Pinson
Director of Oncology
Matt Casillas
Manager, Business Development
Mitchell Morris
Manager, Corporate Development & Strategy
Catie Neel
Event Manager

Meet with us!

Name(Required)
By submitting, you are agreeing to our terms and privacy policy